Scoggin Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Scoggin Management’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-150,000	Closed	-$206K	–	84
2023 Q3	$206K	Hold	150,000	–	–	0.08%	59
2023 Q2	$378K	Hold	150,000	–	–	0.25%	38
2023 Q1	$341K	Buy	150,000 +650	+0.4%	+$1.65K	0.2%	43
2022 Q4	$209K	Sell	149,350 -101,819	-41%	-$171K	0.17%	38
2022 Q3	$497K	Sell	251,169 -30,000	-11%	-$62.4K	0.35%	32
2022 Q2	$441K	Hold	281,169	–	–	0.21%	38
2022 Q1	$1.21M	Hold	281,169	–	–	0.33%	36
2021 Q4	$1.58M	Buy	+281,169	New	+$2.91M	0.45%	36

Other funds holding VAXX

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Scoggin Management's VAXX Position: Q4 2023 in Review

Scoggin Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q4 2023, closing a stake of 150,000 shares — an estimated $206K sold.

Scoggin Management first reported a position in VAXX in Q4 2021 and held it in 8 quarters. The position peaked at $1.58M in Q4 2021. 59 funds tracked by Wall St. Rank hold VAXX as of Q4 2023.

Scoggin Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
Scoggin Management sold 150,000 Vaxxinity, Inc. Class A Common Stock shares in Q4 2023, an estimated $206K.
Scoggin Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 8 quarters.
Scoggin Management's Vaxxinity, Inc. Class A Common Stock position peaked at $1.58M in Q4 2021.
59 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q4 2023.

Based on Scoggin Management's 13F filing for Q4 2023, filed 14 Feb 2024.